(CLARI) Clariane SE - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010386334

CLARI: Care, Nursing, Housing, Home, Support, Services

Clariane SE, formerly known as Korian, is a prominent player in the European healthcare sector, specializing in care homes, healthcare services, and shared living solutions. Established in 2001 and headquartered in Paris, the company rebranded as Clariane SE in June 2023, signaling a strategic shift towards a more integrated and compassionate care approach.

Their service portfolio is comprehensive, encompassing long-term and short-stay nursing homes, outpatient diagnosis programs, and a range of healthcare services including hospitalization and day care. Additionally, Clariane operates post-acute rehabilitation centers, mental health clinics, and community nursing facilities, addressing diverse patient needs across the care continuum.

With operations spanning France, Germany, Benelux, Italy, Spain, and the United Kingdom, Clariane leverages its extensive geographical reach to cater to an aging European population, a demographic driving demand for healthcare services. This diversified presence underscores their strategic strength in navigating varied regulatory and cultural landscapes.

Financially, Clariane boasts a market capitalization exceeding €1 billion, indicating significant market presence. The forward P/E ratio of 36.10 suggests investor confidence in future growth prospects. Notably, the low P/B and P/S ratios may reflect undervaluation or asset-intensive operations, warranting closer examination by investors and fund managers assessing potential opportunities in the healthcare sector.

Additional Sources for CLARI Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

CLARI Stock Overview

Market Cap in USD 1,167m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Facilities
IPO / Inception

CLARI Stock Ratings

Growth 5y -71.5%
Fundamental 0.83%
Dividend 2.11%
Rel. Strength Industry 174
Analysts -
Fair Price Momentum 2.69 EUR
Fair Price DCF 28.34 EUR

CLARI Dividends

Dividend Yield 12m 0.00%
Yield on Cost 5y %
Annual Growth 5y -100.00%
Payout Consistency 69.5%

CLARI Growth Ratios

Growth Correlation 3m 90.5%
Growth Correlation 12m 47.6%
Growth Correlation 5y -90.7%
CAGR 5y -33.15%
CAGR/Max DD 5y -0.34
Sharpe Ratio 12m 1.44
Alpha 113.74
Beta 1.83
Volatility 51.99%
Current Volume 1296.8k
Average Volume 20d 1965.7k
What is the price of CLARI stocks?
As of February 22, 2025, the stock is trading at EUR 3.05 with a total of 1,296,791 shares traded.
Over the past week, the price has changed by +5.98%, over one month by +38.04%, over three months by +73.87% and over the past year by +180.71%.
Is Clariane SE a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Clariane SE is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 0.83 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLARI as of February 2025 is 2.69. This means that CLARI is currently overvalued and has a potential downside of -11.8%.
Is CLARI a buy, sell or hold?
Clariane SE has no consensus analysts rating.
What are the forecast for CLARI stock price target?
According to ValueRays Forecast Model, CLARI Clariane SE will be worth about 2.9 in February 2026. The stock is currently trading at 3.05. This means that the stock has a potential downside of -3.61%.
Issuer Forecast Upside
Wallstreet Target Price 2 -33.1%
Analysts Target Price - -
ValueRay Target Price 2.9 -3.6%